Premium accounts now available! Sign up and create a premium account. Read more Close

Advertisement

Image

Iron-deficiency in the tumor microenvironment reprograms tumor-immune interactions in a sex biased manner

Preprint Created on 03 Jun 2026 bioRxiv

Background: Glioblastoma (GBM) is a sex-biased disease characterized by higher incidence and poorer survival in males. These sex differences are primarily driven by metabolic and immune signatures, with iron metabolism playing a major role. While iron is essential for tumor cell proliferation, it is also critical for T cell recruitment and function within the tumor microenvironment (TME). Clinical data indicates that iron deficiency impacts GBM survival in a sex-biased manner; however, the underlying mechanisms remain unexplored. Methods: We employed a FTH1 heterozygous knockdown mouse model to induce tumor iron deficiency in GBM-bearing mice. TME dynamics were interrogated using flow cytometry and spatial transcriptomics (10X Xenium) to analyze immune infiltration, localization, and ligand-receptor signaling between GBM and immune cells. Results: FTH1 knockdown resulted in iron deficiency in the GBM TME. Iron deficiency altered the TME dynamics in a sex biased manner. FTH1 knockdown in females caused an anti-inflammatory, cytokine deficient TME which failed to recruit CD4 and CD8 T cells. In males, FTH1 knockdown caused a proinflammatory environment by activating the innate immune response. Additionally, FTH1 knockdown increased the density of TAMs in the immediate surrounding of GBM cells in a sex biased manner. Conclusion: These results demonstrate that tumor iron plays a sex-biased role in immune infiltration and anti-tumor immunity.

Sahu, A. P., Hao, Y., Baker, A., Palsa, K., Helmuth, T., Shenoy, G., Neely, E. B., Slagle-Webb, B., Berens, M. E., Connor, J.

Advertisement

Stats

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement